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Background/Aims: The incidence of colorectal cancer 
is increasing in Korea, but the epidemiology of color-
ectal neoplasm is not clearly defined. We aimed to 
elucidate the prevalence of colorectal neoplasm in 
average-risk Koreans and explore the underlying risk 
factors. Methods: A large-scale, multicenter, prospec-
tive study was conducted. Of the 19,460 subjects who 
underwent colonoscopy at 11 university hospitals, we 
analyzed 3,951 consecutive asymptomatic adults with 
no risk factors for colorectal cancer. Results: The 
subjects were aged 52.1±11.6 years (mean±SD) and 
60.1% of them were men. The prevalences of color-
ectal neoplasm and advanced neoplasm were 33.3% 
and 2.2%, respectively. The prevalence of a neoplasm 
increased with age (trend: p＜0.001) and was higher 
in males (p＜0.001). The prevalence of a proximal ne-
oplasm was higher in subjects with a distal neoplasm 
than in those without a distal neoplasm (11.9% vs. 
5.4%, p＜0.001). However, 150 (52.1%) of the 288 
subjects with a proximal neoplasm had no distal 
neoplasm. Conclusions: The overall prevalence of 
colorectal neoplasm in asymptomatic average-risk Ko-
reans is comparable with that in Western countries. 
Being male and older are associated with a higher 
risk of colorectal neoplasm. Over half of proximal neo-
plasms are not associated with any distal sentinel 
lesions. (Gut and Liver 2009;3:35-40)
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INTRODUCTION
  Colorectal cancer is one of the most common malig-
nancies in Western countries and the second leading 
cause of cancer death in the United States.1 Colorectal 
cancer incidence rates appear to be increasing in Asian 
countries.2-4 There has been remarkable increase of color-
ectal cancer and cancers of the lung, the liver, the stom-
ach, and the colorectum, in that order, are the most com-
mon causes of cancer death in Koreans.5 Cancers of the 
stomach and the liver have traditionally predominated in 
Korea, but the incidence rates of those cancers have been 
declining gradually, while that of colorectal cancer has 
continued to increase. 
  Because most colorectal cancers develop from ad-
enomas, the incidence and mortality of colorectal cancer 
can be reduced when precursor adenomas are removed.6,7 
Based upon this adenoma-carcinoma sequence and epi-
demiologic data about colorectal neoplasm, guidelines for 
the prevention, early diagnosis and treatment of colorectal 
cancer have been recently published in Western 
countries.8-10 In Korea, the Korean Society of Coloprocto-
logy and National Cancer Center recommended a guide-
line for colorectal cancer screening and surveillance in 
2001.11 However, the guideline was made without the 
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Table 1. Age Distribution of the 3,951 Subjects
Age group
(years)
Number of patients (%)
Male Female
20-29   51 (1.3)   66 (1.7)
30-39  286 (7.2)  184 (4.7)
40-49  635 (16.1)  422 (10.7)
50-59  747 (18.9)  460 (11.6)
60-69  497 (12.6)  344 (8.7)
70-  158 (4.0)  101 (2.6)
Total 2,374 (60.1) 1,577 (39.9)
support of robust data about the epidemiology of color-
ectal neoplasm in Korean. Accordingly, the usefulness of 
flexible sigmoidoscopy as a screening tool or the rele-
vance of the start of colorectal cancer screening at age 50 
years in asymptomatic average-risk Korean was not eval-
uated enough.
  We conducted a prospective, multicenter colonoscopy 
survey to evaluate the prevalence of colorectal neoplasm 
in average-risk Koreans and explore risk factors for color-
ectal neoplasm. 
MATERIALS AND METHODS
1. Study population
  We aimed to prospectively include consecutive asympto-
matic Korean adults who were undergoing colonoscopy as 
a screening procedure in 11 university hospitals from July 
2003 to June 2004. A total of 19,460 colonoscopies were 
performed during the study period. Subjects were ex-
cluded if they met one of the following criteria: (i) symp-
toms of lower gastrointestinal tract disease, including rec-
tal bleeding, changes in bowel habits, or lower abdominal 
pain that required medical evaluation; (ii) family history 
of colorectal cancer or adenomatous polyps in first-degree 
relatives; (iii) personal history of colorectal cancer, pol-
yps, or inflammatory bowel disease; or (iv) history of col-
orectal examination (including sigmoidoscopy, colono-
scopy, or barium enema) within the previous 10 years, or 
colorectal surgery. In addition, subjects whose colono-
scopy failed to reach the cecum were excluded from the 
analysis. Finally, 3,951 asymptomatic subjects who had a 
complete colonoscopy as the primary screening procedure 
were analyzed in this study. Informed consent was ob-
tained from all subjects and this study was carried out in 
accordance with the Helsinki Declaration.12
2. Study procedures
  Colonoscopies were performed at the participating cen-
ters by experienced colonoscopists. Examinations were 
considered complete when a colonoscope reached the 
cecum. During the examination, all polypoid lesions were 
documented for location and size. The distal colon was 
defined as the rectum, sigmoid colon and descending 
colon. The proximal colon was defined as the splenic flex-
ure and the more proximal portions of the colon. The 
size of each polyp was estimated by the use of an 
8-mm-diameter open-biopsy forceps.
  All the polyps were biopsied or polypectomized, and the 
obtained specimens were sent to pathology laboratories at 
the participating centers for the histologic examination. 
  Colorectal neoplasm was defined as an adenoma or in-
vasive cancer. Invasive cancer was defined as the invasion 
of malignant cells beyond the muscularis mucosa. Ad-
vanced adenoma was defined as an adenoma with a diam-
eter of 10 mm or more, a villous adenoma (i.e., at least 
25% villous architecture), or an adenoma with high grade 
dysplasia. Advanced neoplasm was defined as an advanced 
adenoma or invasive cancer. Patients with multiple neo-
plasms were categorized on the basis of their most ad-
vanced lesion to determine the prevalence of the patho-
logic features. For example, a patient with a villous ad-
enoma and a tubular adenoma was categorized as having 
a villous adenoma. Finding such as hyperplastic or in-
flammatory polyp was regarded as non-neoplastic lesion.
  All the data collected prospectively at the participating 
centers were recorded in Microsoft Access database de-
signed by the Korean Association for the Study of 
Intestinal Diseases (KASID). After the end of the study 
period, all the database at each center were collected and 
merged for the analyses.
3. Statistical analysis
  Statistical analyses were performed with SPSS version 
12.0 (SPSS Inc, Chicago, IL, USA). When appropriate, re-
sults were expressed as proportions, means and standard 
deviations (SD). The Pearson χ2 test, Fisher’s exact test, 
and the likelihood ratio test for trend were used to assess 
relationship between age, gender, and prevalence of 
neoplasm. A p-value less than 0.05 was considered stat-
istically significant.
RESULTS
1. Characteristics of study population
  A total of 3,951 subjects who met the study criteria 
were included for the analyses. Among them, 2,374 were 
men (60.1%). The mean age (±SD) was 52.1±11.6 years 
(range, 20-86 years). In this cohort, 2,307 subjects 
(58.4%) were 50 years or older. Demographic data is 
shown in Table 1. 
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Table 2. Colonoscopy Findings according to the Most Ad-
vanced Lesion
Total ≥50 yr ＜50 yr
Finding
(n=3,951) (n=2,307) (n=1,644)
Overall 1,310 (33.2%) 939 (40.7%) 371 (22.6%)
 neoplasm
Adenomas 1,305 (33.1%) 934 (40.5%) 371 (22.6%)
Advanced   84 (2.1%)  57 (2.5%)  27 (1.6%)
 adenomas
Invasive cancers     5 (0.1%)   5 (0.2%)   0 (0.0%)
Table 3. Prevalence of Colorectal Neoplasm according to 
Gender
Male
(n=2,374)
Female
(n=1,577)
p-value
Overall neoplasm 948 (39.9%) 362 (23.0%) ＜0.001
Non-advanced adenomas 877 (36.9%) 344 (21.8%) ＜0.001
Advanced adenomas  66 (2.8%)  18 (1.1%) ＜0.001
Invasive cancers   5 (0.2%)   0 (0.0%) 0.164
Fig. 1. Prevalence of colorectal neoplasm according to age 
group. The prevalence of colorectal neoplasm increased with 
age (trend: p＜0.001).
Table 4. Colonoscopy Findings in the Distal and Proximal 
Colon
Finding
Number of patients (%)
Total colon Distal colon
Proximal 
colon
All patients (n=3,951)
Overall neoplasm 1,310 1,160 288
(33.2%) (29.4%) (7.3%)
  Non-advanced 1,221 1,095 255
   adenomas (30.9%) (27.7%) (6.5%)
  Advanced 84 60 33
   adenomas (2.1%) (1.5%) (0.8%)
  Invasive cancers 5 5 0 
(0.1%) (0.1%) (0.0%)
Fig. 2. Risk of proximal neoplasm according to distal-colon 
findings (p＜0.001).
2. Prevalence of colorectal neoplasm
  Among the 3,951 asymptomatic subjects, 1,310 (33.2%) 
were found to have colorectal neoplasm (non-advanced 
adenoma 31.0%; advanced adenoma 2.1%; invasive cancer 
0.1%) (Table 2). When the analysis was restricted to the 
2,307 subjects who were 50 years or older, the prevalence 
of colorectal neoplasm increased to 40.7% (non-advanced 
adenoma 38.0%; advanced adenoma 2.5%; invasive cancer 
0.2%).
  The prevalence of colorectal neoplasm was higher in 
men (948/2,374, 39.9%) than in women (362/1,577, 
23.0%) (p＜0.001) (Table 3). The prevalence of overall 
colorectal neoplasm significantly increased with age (trend: 
p＜0.001) (Fig. 1). Also, the prevalence of advanced ad-
enoma increased with age (trend: p＜0.001). 
3. Distribution of colorectal neoplasm
  Of the 1,310 patients with colorectal neoplasm, 1,160 
(88.5%) had their neoplasm in the distal colon, 288 
(22.0%) in the proximal colon, and 138 (10.5%) had 
their neoplasm found in both the proximal and the distal 
colon (Table 4). One hundred thirty-eight subjects 
(11.9%) out of 1,160 with distal neoplasm had proximal 
neoplasm as well, while only 150 of 2,791 subjects 
(5.4%) without colorectal neoplasm in the distal colon 
had colonic neoplasm in the proximal colon (p＜0.001) 
(Fig. 2). Of the 288 patients with proximal neoplasm, 
138 (47.9%) had their neoplasm in the distal colon as 
well, but, 150 (52.1%) had no distal neoplasm. Of the 33 
patients with proximal advanced neoplasm, 11 (33.3%) 
did not have any neoplasm in the distal colon. The preva-
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Fig. 3. Risk of proximal advanced adenoma according to 
distal-colon findings (trend: p＜0.001).
lence of proximal advanced neoplasm increased as the his-
tologic grade of distal neoplasm advanced (trend: p＜ 
0.001) (Fig. 3). 
DISCUSSION
  The incidence of colorectal cancer has been recently ris-
ing in South Korea because of the westernization of life-
styles and dietary habits, and the colorectal cancer screen-
ing is a growing concern. As a result, the National Cancer 
Center recommended a guideline for colorectal cancer 
screening and the National Health Insurance Corporation 
started colorectal cancer screening with annual fecal oc-
cult blood test since 2004.13 However, these guidelines 
were established based on the data in Western countries 
because of a lack of reliable epidemiological data in 
Korea.14,15 Although a large cohort colonoscopy survey in 
asymptomatic Korean was recently reported, this survey 
was a single center study which cannot represent the sta-
tus of general Korean population.16 Therefore, we con-
ducted a prospective, multicenter colonoscopy survey to 
evaluate the prevalence of colorectal neoplasm in aver-
age-risk Koreans and explore risk factors for colorectal 
neoplasm. We, therefore, suggest that the results of this 
study have important implications as the baseline data for 
the preparation of Korean guideline of colorectal cancer 
screening.
  In the present study, we found that the prevalence of 
overall colorectal neoplasm and advanced neoplasm 
among asymptomatic Koreans were 33.2% (1,310/3,951) 
and 2.2% (89/3,951), respectively. The prevalence of 
overall colorectal neoplasm ranged from 20.4% to 37.5% 
and that of advanced neoplasm ranged from 4.9% to 
10.5% in Western studies.17-19 These results indicate that 
the prevalence of advanced neoplasm in average-risk 
Koreans may be slightly lower than that of westerners 
while the prevalence of overall colorectal neoplasm in 
average-risk Koreans may be similar to that of westerners. 
The reason why there is a discrepancy about advanced 
and non-advanced neoplasm between Korean and western-
ers is uncertain and it may be multifactorial including 
both genetic and environmental issues. Considering the 
continuous increase of colorectal cancer in Korea, one can 
imagine that it may be now a transition period from low 
to high prevalence of advanced neoplasm in Korea. 
Putting this result and assumption together with already 
high prevalence of non-advanced neoplasm, colorectal can-
cer screening is certainly necessary and should be strate-
gically launched and performed in Korea. 
  It has been reported that the prevalence of adenomas 
and colorectal cancers is about 1.3- to 1.5-fold higher 
among men than among women in Western studies.20,21 
Similarly, the prevalence of overall neoplasm in men was 
1.7-fold higher than that in women in this study. It, also, 
is well known that old age is a demographic risk factor 
for colorectal neoplasm in Western studies.22 In this 
study, the prevalence of overall colorectal neoplasm and 
advanced adenoma significantly increased with age. This 
is consistent with reports from the West.18,22-24 The fact 
that male sex and old age were independent risk factors 
for colorectal neoplasm in average-risk Koreans, therefore, 
might help in the selection of suitable candidates for 
screening. The current guidelines in Western countries 
recommend that men and women of average-risk should 
be offered screening beginning at age 50 years.8-10 Our re-
sults showed that the prevalence of colorectal neoplasm 
was 28.1% in age 40 to 49 years. When considering these 
results, we suggest that primary screening may be started 
at age 40, especially in men. However, this study re-
cruited asymptomatic subjects who “self referred” for co-
lonoscopy screening. In addition, the participating centers 
were university hospitals which were not distributed 
evenly throughout the nation and were located mainly in 
urban area. Therefore this cohort was not the ideal repre-
sentation of the general population. We think that it is 
necessary to derive the optimal starting age for screening 
based on more strictly nationwide studies with repre-
sentative cases. In addition, the goal of screening is the 
reduction of the death from advanced colorectal cancer, 
not the detection of colorectal adenoma. All the invasive 
cancers were detected in those over 50 years in this 
study. Therefore, the cost-effectiveness of earlier detection 
of early colorectal adenomas in young subjects and their 
colonoscopic resection must also be thoroughly analyzed 
in order that the uniform application of nationwide 
screening from the age less than 50 years could be 
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started.
  It is well known that the presence of distal neoplasm is 
significant predictor for proximal neoplasm, and this is a 
reason why sigmoidoscopy can be included as a screening 
tool.15,23,25-27 Our results were similar to those of the 
West. In our cohort, 52.1% (150/288) of subjects with 
proximal colorectal neoplasm had no distal neoplasm and 
33.3% (11/33) of subjects with proximal advanced neo-
plasm did not have any neoplasm in the distal colon. 
These are similar to the value of 52-62% reported in cor-
responding studies from the West and Korea.17,23,28 There-
fore, from the viewpoint of effectiveness of the detection 
of colorectal neoplasm based on current data, a strategy 
that a full colonoscopy is performed only in patients with 
distal neoplasm detected by prior sigmoidoscopy might be 
insufficient in Korea as well as in Western countries. 
Rather, a primary colonoscopy screening appears to be 
more effective. In addition, if we assume that sigmoido-
scopy in real practice can investigate only rectum and sig-
moid colon and adopt the strategy of whole colonoscopy 
only in those with distal neoplasm in initial sigmoido-
scopy, we would miss more proximal neoplasm than the 
results of our present study which adopted the definition 
of distal neoplasm as rectum, sigmoid colon and descend-
ing colon. Therefore, the value of a primary colonoscopy 
screening may be larger than that based upon the analysis 
in our present study. However, to adopt colonoscopy as a 
primary screening tool in whole population requires sev-
eral prerequisites to be solved. First, quality of colono-
scopy should be controlled. Second, safety concern should 
be settled. Third, acceptance rate for screening colono-
scopy by general population should be increased. Finally, 
most of all, thorough investigation of cost-effectiveness of 
primary colonoscopy screening should be preceded.
  This study has several limitations. First, a possible se-
lection bias exists as previously described because of the 
inclusion of self-referred asymptomatic subjects and un-
even distribution of participating centers. They are likely 
to be the more health-conscious and higher socio-
economic group. Second, other known risk factors for col-
orectal cancer have not been assessed, such as cigarette 
smoking, alcohol consumption and dietary habits. Finally, 
as in multicenter study, interobserver variation among co-
lonoscopists may affect the findings. It is possible that 
pathologists in the local centers may also vary in their in-
terpretation of the severity of dysplasia and, hence, the 
diagnosis of advanced lesions. In this study, actually, the 
prevalence of proximal neoplasm and advanced neoplasm 
tended to be lower than those seen in previous studies in 
Korea.14-16 It may be partly explained by the fact that 
there were both interobserver variation among colono-
scopists and pathologists. 
  Despite these limitations, we believe that this study is 
valuable because it represents the first consorted effort in 
Korea to investigate the prevalence of colorectal neoplasm 
in average-risk Koreans in a prospective manner at 11 
university hospitals. We found that the prevalence of col-
orectal neoplasm in asymptomatic average-risk Koreans 
was similar to the reported prevalence in corresponding 
studies of westerners while the prevalence of advanced 
neoplasm was lower than those observed in westerners. 
We also identified that male and advancing age were risk 
factors for colorectal neoplasm. In conclusion, we suggest 
that the epidemiology of colorectal neoplasm in Korea is 
not much different from westerners and strategic color-
ectal cancer screening should be settled.
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